Literature DB >> 24002773

Clinical significance of incidental pulmonary nodules in esophageal cancer patients.

Amin Madani1, Jonathan Spicer, Thierry Alcindor, Marc David, Marie Vanhuyse, Jamil Asselah, David Mulder, Lorenzo Ferri.   

Abstract

INTRODUCTION: Incidental pulmonary nodules are frequently identified during staging investigations for esophageal cancer patients. Their clinical significance is unclear and may bias treatment decisions towards palliative options.
METHODS: From 2005 to 2011, 423 esophageal cancer patients were treated at a tertiary hospital. Those with incidental pulmonary nodules were identified. Demographics, imaging, pathology and perioperative outcomes were analyzed.
RESULTS: Ninety-two patients (22 %) had lung nodules. Twenty-nine (32 %) were palliative due to poor performance status or extra-pulmonary distant metastasis on imaging. Sixty-three had no evidence of extra-pulmonary metastasis and underwent curative-intent treatment comprising of neoadjuvant therapy [35 (55 %)] followed by esophagectomy [with lung resection, 33 (52 %) or without lung resection, 30 (48 %)]. Of those 33 lung resections, there were 27 benign lesions, 4 stage I lung cancers, and 1 esophageal cancer metastasis. Of 30 patients with lung nodules that underwent curative esophagectomy without lung resection, none showed interval size increase on follow-up imaging [median 9 months (3-40)]. There was no difference in perioperative complications or mortality between patients with combined esophagectomy and lung resection and those with esophagectomy alone.
CONCLUSION: Incidental pulmonary nodules in the absence of extra-pulmonary metastases in esophageal cancer patients are rarely metastases and should not bias caregivers towards palliative therapy.

Entities:  

Mesh:

Year:  2013        PMID: 24002773     DOI: 10.1007/s11605-013-2339-6

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  21 in total

1.  Proposed classification of complications of surgery with examples of utility in cholecystectomy.

Authors:  P A Clavien; J R Sanabria; S M Strasberg
Journal:  Surgery       Date:  1992-05       Impact factor: 3.982

2.  Is surgical treatment of cancer of the gastric cardia or esophagus associated with a concurrent major pulmonary operation feasible? One center's experience.

Authors:  Xiao-Xin Wang; Tong-Lin Liu; Pei Wang; Jian Li
Journal:  Chin Med J (Engl)       Date:  2012-01       Impact factor: 2.628

3.  Simultaneous operation of concomitant diseases in the esophagus and lung.

Authors:  Y Zhu; Q Pu; Lin Ma; J Mei; L Chen; G Che; Z Wu; L Liu
Journal:  Dis Esophagus       Date:  2010-11-18       Impact factor: 3.429

4.  Positron emission tomography with F-18-fluorodeoxyglucose in a combined staging strategy of esophageal cancer prevents unnecessary surgical explorations.

Authors:  Henderik L van Westreenen; Pierre A M Heeren; Hendrik M van Dullemen; Eric J van der Jagt; Pieter L Jager; Henk Groen; John Th M Plukker
Journal:  J Gastrointest Surg       Date:  2005-01       Impact factor: 3.452

5.  Lung cancer screening with CT: Mayo Clinic experience.

Authors:  Stephen J Swensen; James R Jett; Thomas E Hartman; David E Midthun; Jeff A Sloan; Anne-Marie Sykes; Gregory L Aughenbaugh; Medy A Clemens
Journal:  Radiology       Date:  2003-01-24       Impact factor: 11.105

6.  Continuing rapid increase in esophageal adenocarcinoma in England and Wales.

Authors:  Côme Lepage; Bernard Rachet; Valérie Jooste; Jean Faivre; Michel P Coleman
Journal:  Am J Gastroenterol       Date:  2008-10-03       Impact factor: 10.864

7.  Baseline findings of a randomized feasibility trial of lung cancer screening with spiral CT scan vs chest radiograph: the Lung Screening Study of the National Cancer Institute.

Authors:  John Gohagan; Pamela Marcus; Richard Fagerstrom; Paul Pinsky; Barnett Kramer; Philip Prorok
Journal:  Chest       Date:  2004-07       Impact factor: 9.410

8.  Pulmonary nodules in patients with esophageal carcinoma.

Authors:  M L Margolis; P Howlett; R Bubanj
Journal:  J Clin Gastroenterol       Date:  1998-06       Impact factor: 3.062

9.  Cancer statistics, 2009.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Yongping Hao; Jiaquan Xu; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2009-05-27       Impact factor: 508.702

10.  Incidence and distribution of distant metastases from newly diagnosed esophageal carcinoma.

Authors:  L E Quint; L M Hepburn; I R Francis; R I Whyte; M B Orringer
Journal:  Cancer       Date:  1995-10-01       Impact factor: 6.860

View more
  5 in total

1.  Predictive factors for malignancy in incidental pulmonary nodules detected in breast cancer patients at baseline CT.

Authors:  Mark M Hammer; Eduardo J Mortani Barbosa
Journal:  Eur Radiol       Date:  2016-10-31       Impact factor: 5.315

2.  Incidental nonneoplastic parenchymal findings in patients undergoing lung resection for mass lesions.

Authors:  Yin P Hung; Gary M Hunninghake; Ezra R Miller; Rachel Putman; Mizuki Nishino; Tetsuro Araki; Hiroto Hatabu; Lynette M Sholl; Marina Vivero
Journal:  Hum Pathol       Date:  2019-01-15       Impact factor: 3.466

3.  Prediction of pulmonary metastasis in pulmonary nodules (≤10 mm) detected in patients with primary extrapulmonary malignancy at thin-section staging CT.

Authors:  Qiuxia Yang; Yiqi Wang; Xiaohua Ban; Jing Wu; Dailin Rong; Qianqian Zhao; Chuanmiao Xie; Rong Zhang
Journal:  Radiol Med       Date:  2017-07-18       Impact factor: 3.469

4.  Incidentalomas during imaging for primary hyperparathyroidism--incidence and clinical outcomes.

Authors:  P Prasad; C Clout; E Lorenz; B J Harrison; S P Balasubramanian
Journal:  World J Surg Oncol       Date:  2015-09-17       Impact factor: 2.754

5.  Identification of second primary tumors from lung metastases in patients with esophageal squamous cell carcinoma using whole-exome sequencing.

Authors:  Liyan Xue; Weihua Li; Xinyi Fan; Zitong Zhao; Wei Zhou; Zhimin Feng; Linxiu Liu; Hua Lin; Lin Li; Xuemin Xue; Xuanlin Huang; Peide Huang; Jia Guo; Peina Du; Ning Lu; Lin Li; Qimin Zhan; Yongmei Song
Journal:  Theranostics       Date:  2020-08-25       Impact factor: 11.556

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.